Jiwei Sheng, MD
Retina Specialist · Fairfax, VANPI 1679064075
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,957 of the $7,864 with a category attached, or 75.8%. It is spread thinly across 19 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.
Across 108 payments — averaging $72.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- AbbVie$1K
- Ocular Therapeutix, Inc.$897
- Regeneron Healthcare Solutions, Inc.$742
- Genentech USA, Inc.$695
- Neurotech Pharmaceuticals, Inc.$447
- plus $2K from 13 others
What the payments were for
- Travel & lodging$1,80623%
- Food & beverage$5,95776%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 7 | $1,618 |
| AbbVie(2 entities) | 36 | $1,004 |
| Ocular Therapeutix, Inc. | 5 | $897 |
| Regeneron Healthcare Solutions, Inc. | 16 | $742 |
| Genentech USA, Inc. | 7 | $695 |
| Neurotech Pharmaceuticals, Inc. | 3 | $447 |
| Astellas Pharma US Inc | 5 | $387 |
| Dutch Ophthalmic, USA | 2 | $360 |
| NEW World Medical,inc. | 3 | $287 |
| Apellis Pharmaceuticals, Inc. | 6 | $242 |
| Bausch & Lomb Americas Inc. | 4 | $179 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $165 |
| Alimera Sciences, Inc. | 2 | $159 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $147 |
| Biotissue Holdings Inc. | 1 | $137 |
| Glaukos Corporation | 1 | $133 |
| Iridex Corporation | 1 | $120 |
| Sight Sciences, Inc. | 1 | $106 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$390
- EVA, combined machine$360
- TISSUEBLUE$360
- Izervay$332
- SUSVIMO$245
- EYLEA HD$240
- OZURDEX$205
- AcrySof IQ VIVITY IOL$150
- AcrySof IQ PanOptix$150
- Prokera$137
- iStent inject Trabecular Micro-Bypass Stent System$133
- Photrexa$133
- Syfovre$121
- Iluvien$119
- XIPERE$117
- Ahmed Glaucoma Valve$116
- Kahook Dual Blade$116
- TRYPTYR$115
- Tecnis IOL$115
- Tecnis Simplicity$115
How this compares
$7,864 in reported general payments places this provider in the 80th percentile of 41 retina specialist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 15 | $545 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Fairfax
- Alexander MelamudFairfax$6K
- John MinarcikFairfax$805
- Amir HaririFairfax$556
- Samuel YunFairfax$51
- Jordana FeinManassas$412K
- Joaquin TosiVirginia Beach$48K
- Mohit NandaCharlottesville$31K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.